Exogenous expression of HIF-1α promotes cardiac differentiation of embryonic stem cells

Journal of Molecular and Cellular Cardiology

Volumn 48, Issue 6, 2010, Pages 1129-1137

  Ng, Kwong Man ^a,b   Lee, Yee Ki ^b   Chan, Yau Chi ^b   Lai, Wing Hon ^b   Fung, Man Lung ^a,b   Li, Ronald A ^a,b,c,d,e   Siu, Chung Wah ^a,b   Tse, Hung Fat ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e SHRINERS HOSPITALS FOR CHILDREN NORTHERN CALIFORNIA   (United States)

Author keywords

Cardiomyocytes; Embryonic stem cells; Hypoxia; Hypoxia inducible factor 1 ; Sarcoplasmic reticulum function

Indexed keywords

CARDIOTROPHIN 1; COMPLEMENTARY DNA; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN BETA; MYOSIN LIGHT CHAIN 2; RYANODINE RECEPTOR 2; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SODIUM CALCIUM EXCHANGE PROTEIN; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR GATA 6; TROPONIN T; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL MEMBRANE DEPOLARIZATION; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; ENDOPLASMIC RETICULUM; ERYTHROID CELL; GENE EXPRESSION REGULATION; HEART DEVELOPMENT; HEART MUSCLE CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

MURINAE;

EID: 77952670050     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.01.015     Document Type: Article

References (51)

1. Fukuda K., Yuasa S. Stem cells as a source of regenerative cardiomyocytes. Circ. Res. 2006, 2006(98):1002-1013.
2. Hare J.M., Chaparro S.V. Cardiac regeneration and stem cell therapy. Curr. Opin. Organ Transplant. 2008, 13:536-542.
3. Strauer B.E., Brehm M., Schannwell C.M. The therapeutic potential of stem cells in heart disease. Cell Prolif. 2008 Feb, 41(Suppl 1):126-145.
4. Smits A.M., van Vliet P., Hassink R.J., Goumans M.J., Doevendans P.A. The role of stem cells in cardiac regeneration. J. Cell. Mol. Med. 2005, 9(1):25-36.
5. Gepstein L. Cardiovascular therapeutic aspects of cell therapy and stem cells. Ann. N.Y. Acad. Sci. 2006, 1080:415-425.
6. Kawai T., Takahashi T., Esaki M., Ushikoshi H., Nagano S., Fujiwara H., et al. Efficient cardiomyogenic differentiation of embryonic stem cell by fibroblast growth factor 2 and bone morphogenetic protein 2. Circ. J. 2004, 68:691-702.
7. Graichen R., Xu X., Braam S.R., Balakrishnan T., Norfiza S., Sieh S., et al. Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK. Differentiation 2008, 76:357-370.
8. Laflamme M.A., Chen K.Y., Naumova A.V., Muskheli V., Fugate J.A., Dupras S.K., et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 2007, 25:1015-1024.
9. Ramirez-Bergeron D.L., Runge A., Dahl K.D.C., Fehling H.J., Keller G., Simon M.C. Hypoxia affects mesoderm and enhances hemangioblast specification during early development. Development 2004, 131:4623-4634.
10. Fisher S.A., Burggren W.W. Role of hypoxia in the evolution and development of the cardiovascular system. Antioxid. Redox Signal. 2007, 9:1339-1352.
11. Simon M.C., Keith B. The role of oxygen availability in embryonic development and stem cell function. Nat. Rev. Mol. Cell Biol. 2008, 9:285-296.
12. Huang L., Li H., Xie Z. Ouabain-induced hypertrophy in cultured cardiac myocytes is accompanied by changes in expression of several late response genes. J. Mol. Cell. Cardiol. 1997, 29:429-437.
13. Xinping Yue R.J.T. Stimulation of coronary vasculogenesis/angiogenesis by hypoxia in cultured embryonic hearts. Dev. Dyn. 1999, 216:28-36.
14. Niebruegge S., Bauwens C.L., Peerani R., Thavandiran N., Masse S., Sevaptisidis E., et al. Generation of human embryonic stem cell-derived mesoderm and cardiac cells using size-specified aggregates in an oxygen-controlled bioreactor. Biotechnol. Bioeng. 2009, 102:493-507.
15. Ezashi T., Das P., Roberts R.M. Low O2 tensions and the prevention of differentiation of hES cells. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:4783-4788.
16. 2 tension. Proc. Natl. Acad. Sci. 1995, 92:5510-5514.
17. Pugh C.W., Ratcliffe P.J. The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis. Semin. Cancer Biol. 2003, 13:83-89.
18. Ateghang B., Wartenberg M., Gassmann M., Sauer H. Regulation of cardiotrophin-1 expression in mouse embryonic stem cells by HIF-1alpha and intracellular reactive oxygen species. J. Cell. Sci. 2006, 119(Pt 6):1043-1052.
19. Ng K.M., Catalano M.G., Pinos T., Selva D.M., Avvakumov G.V., Munell F., et al. Evidence that fibulin family members contribute to the steroid-dependent extravascular sequestration of sex hormone-binding globulin. J. Biol. Chem. 2006, 281:15853-15861.
20. Chan Y.C., Siu C.W., Lau Y.M., Lau C.P., Li R.A., Tse H.F. Synergistic effects of inward rectifier (I) and pacemaker (I) currents on the induction of bioengineered cardiac automaticity. J. Cardiovasc. Electrophysiol. 2009, 20:1048-1054.
21. Moore J.C., van Laake L.W., Braam S.R., Xue T., Tsang S.Y., Ward D., et al. Human embryonic stem cells: genetic manipulation on the way to cardiac cell therapies. Reprod. Toxicol. 2005, 20:377-391.
22. Liu Y., Cox S.R., Morita T., Kourembanas S. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5? enhancer. Circ. Res. 1995, 77:638-643.
23. Levy A.P., Levy N.S., Wegner S., Goldberg M.A. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J. Biol. Chem. 1995, 270:13333-13340.
24. Kanno S., Kim P.K., Sallam K., Lei J., Billiar T.R., Shears L.L. Nitric oxide facilitates cardiomyogenesis in mouse embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:12277-12281.
25. Bloch W., Fleischmann B.K., Lorke D.E., Andressen C., Hops B., Hescheler J., et al. Nitric oxide synthase expression and role during cardiomyogenesis. Cardiovasc. Res. 1999, 43:675-684.
26. Arnet U.A., McMillan A., Dinerman J.L., Ballermann B., Lowenstein C.J. Regulation of endothelial nitric-oxide synthase during hypoxia. J. Biol. Chem. 1996 Jun 21, 271(25):15069-15073.
27. Shannon T.R., Bers D.M. Integrated Ca2+ management in cardiac myocytes. Ann. N. Y. Acad. Sci. 2004 May, 1015:28-38.
28. Chen H.F., Kuo H.C., Chen W., Wu F.C., Yang Y.S., Ho H.N. A reduced oxygen tension (5%) is not beneficial for maintaining human embryonic stem cells in the undifferentiated state with short splitting intervals. Hum. Reprod. 2009 Jan, 24(1):71-80.
29. Blokhina O., Virolainen E., Fagerstedt K.V. Antioxidants, oxidative damage and oxygen deprivation stress: a review. Ann. Bot. (Lond.) 2003, 91(Spec No):179-194.
30. Hermes-Lima M., Zenteno-Savin T. Animal response to drastic changes in oxygen availability and physiological oxidative stress. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2002, 133:537-556.
31. Chandel N.S., Budinger G.R. The cellular basis for diverse responses to oxygen. Free Radic. Biol. Med. 2007, 42:165-174.
32. Guzy R.D., Schumacker P.T. Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia. Exp. Physiol. 2006, 91:807-819.
33. Nanduri J., Nanduri R.P. Cellular mechanisms associated with intermittent hypoxia. Essays Biochem. 2007, 43:91-104.
34. Li J., Stouffs M., Serrander L., Banfi B., Bettiol E., Charnay Y., et al. The NADPH oxidase NOX4 drives cardiac differentiation: role in regulating cardiac transcription factors and MAP kinase activation. Mol. Biol. Cell 2006, 17:3978-3988.
35. Buggisch M., Ateghang B., Ruhe C., Strobel C., Lange S., Wartenberg M., et al. Stimulation of ES-cell-derived cardiomyogenesis and neonatal cardiac cell proliferation by reactive oxygen species and NADPH oxidase. J. Cell. Sci. 2007, 120(Pt 5):885-894.
36. Goyal P., Weissmann N., Grimminger F., Hegel C., Bader L., Rose F., et al. Upregulation of NAD(P)H oxidase 1 in hypoxia activates hypoxia-inducible factor 1 via increase in reactive oxygen species. Free Radic. Biol. Med. 2004, 36:1279-1288.
37. Martinez-Sanchez G., Giuliani A. Cellular redox status regulates hypoxia inducible factor-1 activity. Role in tumour development. J. Exp. Clin. Cancer Res. 2007, 26:39-50.
38. Brewer A.C., Alexandrovich A., Mjaatvedt C.H., Shah A.M., Patient R.K., Pizzey J.A. GATA factors lie upstream of Nkx 2.5 in the transcriptional regulatory cascade that effects cardiogenesis. Stem Cells Dev. 2005, 14:425-439.
39. Harris B.S., Jay P.Y., Rackley M.S., Izumo S., O'Brien T.X., Gourdie R.G. Transcriptional regulation of cardiac conduction system development: 2004 FASEB cardiac conduction system minimeeting, Washington, DC. Anat. Rec. A Discov. Mol. Cell Evol. Biol. 2004, 280:1036-1045.
40. Charron F., Nemer M. GATA transcription factors and cardiac development. Semin. Cell Dev. Biol. 1999, 10:85-91.
41. Molkentin J.D., Antos C., Mercer B., Taigen T., Miano J.M., Olson E.N. Direct activation of a GATA6 cardiac enhancer by Nkx2.5: evidence for a reinforcing regulatory network of Nkx2.5 and GATA transcription factors in the developing heart. Dev. Biol. 2000, 217:301-309.
42. Nagao K., Taniyama Y., Kietzmann T., Doi T., Komuro I., Morishita R. HIF-1{alpha} signaling upstream of NKX2.5 is required for cardiac development in Xenopus. J. Biol. Chem. 2008, 283:11841-11849.
43. Mujoo K., Sharin V.G., Bryan N.S., Krumenacker J.S., Sloan C., Parveen S., et al. Role of nitric oxide signaling components in differentiation of embryonic stem cells into myocardial cells. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:18924-18929.
44. Feliers D., Chen X., Akis N., Choudhury G.G., Madaio M., Kasinath B.S. VEGF regulation of endothelial nitric oxide synthase in glomerular endothelial cells. Kidney Int. 2005, 68:1648-1659.
45. Musicki B., Palese M.A., Crone J.K., Burnett A.L. Phosphorylated endothelial nitric oxide synthase mediates vascular endothelial growth factor-induced penile erection. Biol. Reprod. 2004, 70:282-289.
46. Michell B.J., Griffiths J.E., Mitchelhill K.I., Rodriguez-Crespo I., Tiganis T., Bozinovski S., et al. The Akt kinase signals directly to endothelial nitric oxide synthase. Curr. Biol. 1999, 9:845-848.
47. Bers D.M., Despa S. Cardiac myocytes Ca2+ and Na+ regulation in normal and failing hearts. J. Pharmacol. Sci. 2006, 100:315-322.
48. Satin J., Itzhaki I., Rapoport S., Schroder E.A., Izu L., Arbel G., et al. Calcium handling in human embryonic stem cell-derived cardiomyocytes. Stem Cells 2008, 26:1961-1972.
49. Otsu K., Kuruma A., Yanagida E., Shoji S., Inoue T., Hirayama Y., et al. Na+/K+ ATPase and its functional coupling with Na+/Ca2+ exchanger in mouse embryonic stem cells during differentiation into cardiomyocytes. Cell Calcium 2005, 37:137-151.
50. Trepanier-Boulay V., Lupien M.A., St-Michel C., Fiset C. Postnatal development of atrial repolarization in the mouse. Cardiovasc. Res. 2004, 64:84-93.
51. 2+ wavefronts in mouse and human embryonic stem cell-derived cardiomyocytes. Stem Cells Dev. 2009, 18:1493-1500.